Whereas a cardinal role for beta-amyloid protein (A beta) has been postulated as a major trigger of neuronal injury in Alzheimer's disease, the pathogenic mechanism by which A beta deranges nerve cells remains largely elusive. Here we report correlative in vitro and in vivo evidence that an excitotoxic cascade mediates A beta neurotoxicity in the rat magnocellular nucleus basalis (MBN). In vitro application of A beta to astrocytes elicits rapid depolarization of astroglial membranes with a concomitant inhibition of glutamate uptake. In vivo A beta infusion by way of microdialysis in the MBN revealed peak extracellular concentrations of excitatory amino acid neurotransmitters within 20-30 min. A beta-triggered extracellular elevation of exci...
Background: Despite the clear physical association between activated astrocytes and amyloid-beta (A ...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
beta-Amyloid((1-42)) peptide (beta AP) was injected into the right nucleus basalis magnocellularis (...
Whereas a cardinal role for beta-amyloid protein (A beta) has been postulated as a major trigger of ...
Whereas a cardinal role for β-amyloid protein (Aβ) has been postulated as a major trigger of neurona...
Alzheimer's disease is the most common type of dementia with a still largely unclear etiopathology, ...
Alzheimer's disease is the most common type of dementia with a still largely unclear etiopathology, ...
Ample experimental evidence indicates that acute beta-amyloid infusion into the nucleus basalis of r...
Previous experimental data indicate the involvement of Ca2+-related excitotoxic processes, possibly ...
ABSTRACT: Alzheimer’s disease is the most common type of dementia with a still largely unclear etiop...
Ample experimental evidence indicates that acute beta-amyloid infusion into the nucleus basalis of r...
Alzheimer’s disease is the most common type of dementia with a still largely unclear etiopathology. ...
A putative tetrapeptide beta-amyloid (A beta) antagonist (propionyl-Ile-Ile-Gly-Leu [Pr-IIGL]) based...
Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid ...
Alzheimer disease (AD), the most frequent cause of dementia, is characterized by an important neuron...
Background: Despite the clear physical association between activated astrocytes and amyloid-beta (A ...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
beta-Amyloid((1-42)) peptide (beta AP) was injected into the right nucleus basalis magnocellularis (...
Whereas a cardinal role for beta-amyloid protein (A beta) has been postulated as a major trigger of ...
Whereas a cardinal role for β-amyloid protein (Aβ) has been postulated as a major trigger of neurona...
Alzheimer's disease is the most common type of dementia with a still largely unclear etiopathology, ...
Alzheimer's disease is the most common type of dementia with a still largely unclear etiopathology, ...
Ample experimental evidence indicates that acute beta-amyloid infusion into the nucleus basalis of r...
Previous experimental data indicate the involvement of Ca2+-related excitotoxic processes, possibly ...
ABSTRACT: Alzheimer’s disease is the most common type of dementia with a still largely unclear etiop...
Ample experimental evidence indicates that acute beta-amyloid infusion into the nucleus basalis of r...
Alzheimer’s disease is the most common type of dementia with a still largely unclear etiopathology. ...
A putative tetrapeptide beta-amyloid (A beta) antagonist (propionyl-Ile-Ile-Gly-Leu [Pr-IIGL]) based...
Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid ...
Alzheimer disease (AD), the most frequent cause of dementia, is characterized by an important neuron...
Background: Despite the clear physical association between activated astrocytes and amyloid-beta (A ...
Long-term behavioral effects, changes in learning and memory functions and aberrations of cholinergi...
beta-Amyloid((1-42)) peptide (beta AP) was injected into the right nucleus basalis magnocellularis (...